Free Trial
NASDAQ:HRTS

Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News

$34.51
-0.09 (-0.26%)
(As of 07/26/2024 ET)
Today's Range
$34.38
$34.84
50-Day Range
$31.44
$35.90
52-Week Range
$26.26
$36.03
Volume
11,289 shs
Average Volume
27,313 shs
Market Capitalization
$81.79 million
Assets Under Management
$83.88 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
HRTS stock logo

About Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

HRTS Stock Price History

HRTS ETF News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
NVO Mar 2024 131.000 put
XLV Apr 2024 144.500 put
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Tema Global
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
45

Fund Statistics

Assets Under Management
$83.88 million
Average Daily Volume
$0.00
Discount/Premium
0.08%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
10,900 shs

Miscellaneous

Beta
0.93
Creation Unit
10,000
Creation Fee
$500.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Tema Cardiovascular and Metabolics ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.57%0.50%0.39%0.54%
Total Expense0.99%0.73%0.70%0.61%0.71%
Fee Waiver-0.24%-0.74%-0.54%-0.32%-0.59%
Net Expense0.75%0.59%0.60%0.54%0.58%

Tema Cardiovascular and Metabolics ETF (HRTS) Holdings & Exposure

HRTS Sector Exposure

HRTS Industry Exposure


HRTS ETF - Frequently Asked Questions

How have HRTS shares performed this year?

Tema Cardiovascular and Metabolics ETF's stock was trading at $30.61 at the beginning of 2024. Since then, HRTS stock has increased by 12.7% and is now trading at $34.51.
View the best growth stocks for 2024 here
.

How do I buy shares of Tema Cardiovascular and Metabolics ETF?

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HRTS) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners